Zoetis (ZTS) Other Operating Expenses (2012 - 2021)
Zoetis' (ZTS) quarterly Other Operating Expenses came in at -$405.0 million in Q1 2021, down 406.82% year-on-year from $132.0 million in Q1 2020, and down 5.47% on a QoQ basis from -$384.0 million in Q3 2020.
Zoetis (ZTS) Other Operating Expenses (2012 - 2021) Analysis & Trends
Zoetis (ZTS) has 10 years of Other Operating Expenses data on file, last reported at -$405.0 million in Q1 2021.
- On a quarterly basis, Other Operating Expenses fell 406.82% year-over-year to -$405.0 million in Q1 2021; TTM through Dec 2021 was -$405.0 million, a 35.51% increase from a year earlier, with the FY2019 full-year figure at -$927.0 million, down 8.8% from the prior year.
- Other Operating Expenses for Q1 2021 stood at -$405.0 million, down from -$384.0 million in the prior quarter.
- Over the last five years, Other Operating Expenses for ZTS reached as high as $1.2 billion in Q4 2019 and fell as low as -$405.0 million in Q1 2021.
- Historically, Other Operating Expenses has averaged $413.6 million across 5 years, with a median of $495.5 million in 2017.
- Across the five-year window, Other Operating Expenses surged 1406.06% in 2017 and tumbled 406.82% in 2021, its largest moves.
- Year by year, Other Operating Expenses stood at $535.0 million in 2017, then surged by 108.97% to $1.1 billion in 2018, then grew by 7.42% to $1.2 billion in 2019, then plunged by 131.97% to -$384.0 million in 2020, then fell by 5.47% to -$405.0 million in 2021.
- Per Business Quant data, the three most recent Other Operating Expenses figures were -$405.0 million in Q1 2021, -$384.0 million in Q3 2020, and -$376.0 million in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -405.00 Mn |
| Sep 30, 2020 | -384.00 Mn |
| Jun 30, 2020 | -376.00 Mn |
| Mar 31, 2020 | 132.00 Mn |
| Dec 31, 2019 | 1.20 Bn |
| Sep 30, 2019 | 140.00 Mn |
| Jun 30, 2019 | 168.00 Mn |
| Mar 31, 2019 | 115.00 Mn |
| Dec 31, 2018 | 1.12 Bn |
| Sep 30, 2018 | 968.00 Mn |
| Jun 30, 2018 | 968.00 Mn |
| Mar 31, 2018 | 945.00 Mn |
| Dec 31, 2017 | 535.00 Mn |
| Oct 1, 2017 | 494.00 Mn |
| Jul 2, 2017 | 502.00 Mn |
| Apr 2, 2017 | 497.00 Mn |
| Dec 31, 2016 | 537.00 Mn |
| Oct 2, 2016 | 465.00 Mn |
| Jul 3, 2016 | 487.00 Mn |
| Apr 3, 2016 | 33.00 Mn |